glp 1 drugs pancreatitis why do agonists cause Glucagon-like Peptide 1 Receptor Signaling in Acinar Cells Drug-Induced Acute Pancreatitis: A Review
Description
doi: 10.2337/diabetes.47.4.530
PloS One (2016) 11(7):e0158205
Evidence Builds The SURMOUNT-OSA trial, funded by Eli Lilly, added to this evidence
L., & Rubio-Herrera, M
Elimination and degradation of glucagon-like peptide-1 and glucose-dependent insulinotropic polypeptide in patients with end-stage renal disease
Some GLP-1 agonists have the same generic name but are marketed under a different brand name and are approved for a different purpose, depending on the dose and how they are taken
